Form EFFECT Galmed Pharmaceuticals
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 21, 2024 4:30 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pepe Coin Price Prediction: PEPE Trades Near $0.0000040 as Remittix’s PayFi Tests Put Utility Back in Focus
- Sunrise Orthodontics Explains Two-Phase Treatment in Ponte Vedra Beach
- Polygon Price Prediction: POL Trades Below $0.10 After TRON Payments Expansion as Remittix Builds Its PayFi Launch Case
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share